Lycopene for prevention and treatment Of drostate cancer

被引：9

作者：

Everson, KA ^{[1
]}

McQueen, CE ^{[1
]}

机构：

[1] Univ Missouri, Drug Informat Ctr, Kansas City, MO 64108 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2004年 / 61卷 / 15期

关键词：

D O I：

10.1093/ajhp/61.15.1562

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1562 / +

页数：4

共 20 条

[1]

American Cancer Society, 2002, CANC FACTS FIG 2002

[2] A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer [J].

Ansari, MS ;

Gupta, NP .

BJU INTERNATIONAL, 2003, 92 (04) :375-378

[3]

BASCH E, 2003, NATURAL STANDARD

[4] Bioavailability of all-trans and cis-isomers of lycopene [J].

Boileau, TWM ;

Boileau, AC ;

Erdman, JW .

EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (10) :914-919

[5] The epidemiology of prostate cancer [J].

Boyle, P ;

Severi, G ;

Giles, GG .

UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (02) :209-+

[6]

Carraro JC, 1996, PROSTATE, V29, P231, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt

[7]

231::AID-PROS4&gt

[8]

3.0.CO

[9]

2-E

[10]

DIPIRO JT, 2002, PHARMACOTHERAPY PATH, P2313

← 1 2 →